Literature DB >> 32693220

The dawn of non-human primate models for neurodevelopmental disorders.

Tomomi Aida1, Guoping Feng2.   

Abstract

Non-human primates (NHPs) have been proposed as good models for neurodevelopmental disorders due to close similarities to humans in terms of brain structure and cognitive function. The recent development of genome editing technologies has opened new avenues to generate and investigate genetically modified NHPs as models for human disorders. Here, we review the early successes of genetic NHP models for neurodevelopmental disorders and further discuss the technological challenges and opportunities to create next generation NHP models with more sophisticated genetic manipulation and faithful representations of the human genetic mutations. Taken together, the field is now poised to usher in a new era of research using genetically modified NHP models to empower a more rapid translation of basic research and maximize the preclinical potential for biomarker discovery and therapeutic development.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32693220      PMCID: PMC7955645          DOI: 10.1016/j.gde.2020.05.040

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  71 in total

1.  One-step generation of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas system.

Authors:  Haifeng Wan; Chunjing Feng; Fei Teng; Shihua Yang; Baoyang Hu; Yuyu Niu; Andy Peng Xiang; Weizhen Fang; Weizhi Ji; Wei Li; Xiaoyang Zhao; Qi Zhou
Journal:  Cell Res       Date:  2014-11-28       Impact factor: 25.617

2.  Opportunities and challenges in modeling human brain disorders in transgenic primates.

Authors:  Charles G Jennings; Rogier Landman; Yang Zhou; Jitendra Sharma; Julia Hyman; J Anthony Movshon; Zilong Qiu; Angela C Roberts; Anna Wang Roe; Xiaoqin Wang; Huihui Zhou; Liping Wang; Feng Zhang; Robert Desimone; Guoping Feng
Journal:  Nat Neurosci       Date:  2016-08-26       Impact factor: 24.884

3.  Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9.

Authors:  Yongchang Chen; Yinghui Zheng; Yu Kang; Weili Yang; Yuyu Niu; Xiangyu Guo; Zhuchi Tu; Chenyang Si; Hong Wang; Ruxiao Xing; Xiuqiong Pu; Shang-Hsun Yang; Shihua Li; Weizhi Ji; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2015-04-09       Impact factor: 6.150

Review 4.  Gene hunting in autism spectrum disorder: on the path to precision medicine.

Authors:  Daniel H Geschwind; Matthew W State
Journal:  Lancet Neurol       Date:  2015-04-16       Impact factor: 44.182

5.  CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms.

Authors:  Zhuchi Tu; Hui Zhao; Bang Li; Sen Yan; Lu Wang; Yongjin Tang; Zhujun Li; Dazhang Bai; Caijuan Li; Yingqi Lin; Yuefeng Li; Jianrong Liu; Hao Xu; Xiangyu Guo; Yong-Hui Jiang; Yong Q Zhang; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2019-02-15       Impact factor: 6.150

6.  TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys.

Authors:  Hailiang Liu; Yongchang Chen; Yuyu Niu; Kunshan Zhang; Yu Kang; Weihong Ge; Xiaojing Liu; Enfeng Zhao; Chencheng Wang; Shaoyun Lin; Bo Jing; Chenyang Si; Quan Lin; Xiaoying Chen; Haijun Lin; Xiuqiong Pu; Yingying Wang; Binlian Qin; Fang Wang; Hong Wang; Wei Si; Jing Zhou; Tao Tan; Tianqing Li; Shaohui Ji; Zhigang Xue; Yuping Luo; Liming Cheng; Qi Zhou; Siguang Li; Yi Eve Sun; Weizhi Ji
Journal:  Cell Stem Cell       Date:  2014-02-13       Impact factor: 24.633

7.  Single App knock-in mouse models of Alzheimer's disease.

Authors:  Takashi Saito; Yukio Matsuba; Naomi Mihira; Jiro Takano; Per Nilsson; Shigeyoshi Itohara; Nobuhisa Iwata; Takaomi C Saido
Journal:  Nat Neurosci       Date:  2014-04-13       Impact factor: 24.884

Review 8.  Brains, genes, and primates.

Authors:  Juan Carlos Izpisua Belmonte; Edward M Callaway; Sarah J Caddick; Patricia Churchland; Guoping Feng; Gregg E Homanics; Kuo-Fen Lee; David A Leopold; Cory T Miller; Jude F Mitchell; Shoukhrat Mitalipov; Alysson R Moutri; J Anthony Movshon; Hideyuki Okano; John H Reynolds; Dario Ringach; Terrence J Sejnowski; Afonso C Silva; Peter L Strick; Jun Wu; Feng Zhang
Journal:  Neuron       Date:  2015-05-06       Impact factor: 17.173

9.  Chromosome engineering in zygotes with CRISPR/Cas9.

Authors:  Katharina Boroviak; Brendan Doe; Ruby Banerjee; Fengtang Yang; Allan Bradley
Journal:  Genesis       Date:  2016-01-25       Impact factor: 2.487

10.  TALEN-based generation of a cynomolgus monkey disease model for human microcephaly.

Authors:  Qiong Ke; Weiqiang Li; Xingqiang Lai; Hong Chen; Lihua Huang; Zhuang Kang; Kai Li; Jie Ren; Xiaofeng Lin; Haiqing Zheng; Weijun Huang; Yunhan Ma; Dongdong Xu; Zheng Chen; Xinming Song; Xinyi Lin; Min Zhuang; Tao Wang; Fengfeng Zhuang; Jianzhong Xi; Frank Fuxiang Mao; Huimin Xia; Bruce T Lahn; Qi Zhou; Shihua Yang; Andy Peng Xiang
Journal:  Cell Res       Date:  2016-08-09       Impact factor: 25.617

View more
  4 in total

Review 1.  Emerging strategies for the genetic dissection of gene functions, cell types, and neural circuits in the mammalian brain.

Authors:  Ling Gong; Xue Liu; Jinyun Wu; Miao He
Journal:  Mol Psychiatry       Date:  2021-09-24       Impact factor: 15.992

2.  Epitope-preserving magnified analysis of proteome (eMAP).

Authors:  Joha Park; Sarim Khan; Dae Hee Yun; Taeyun Ku; Katherine L Villa; Jiachen E Lee; Qiangge Zhang; Juhyuk Park; Guoping Feng; Elly Nedivi; Kwanghun Chung
Journal:  Sci Adv       Date:  2021-11-12       Impact factor: 14.957

Review 3.  Harnessing the Power of Stem Cell Models to Study Shared Genetic Variants in Congenital Heart Diseases and Neurodevelopmental Disorders.

Authors:  Xuyao Chang; Mingxia Gu; Jason Tchieu
Journal:  Cells       Date:  2022-01-28       Impact factor: 6.600

Review 4.  CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection.

Authors:  Jenna Kropp Schmidt; Matthew R Reynolds; Thaddeus G Golos; Igor I Slukvin
Journal:  Retrovirology       Date:  2022-08-10       Impact factor: 3.768

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.